2024 Top Story in Oncology: Myeloma and Bispecific Antibodies
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Schubert C. Dr. C. Ola Landgren on Quadruple Therapies and the Future of Multiple Myeloma Treatment. May 23, 2024. Accessed November 12, 2024.
- Moreau P, Garfall AL, van de Donk NWCJ, et al. Teclistamab in Relapsed or Refractory Multiple Myeloma. N Engl J Med. 2022;387(6):495-505.
- Devasia AJ, Chari A, Lancman G. Bispecific antibodies in the treatment of multiple myeloma. Blood Cancer J. 2024;14(1):158.